Nabriva Therapeutics Prices Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Nabriva Therapeutics AG (NBRV) IPO Opens Up 8%
September 18, 2015 11:24 AM EDTToday's IPO for Nabriva Therapeutics AG (NASDAQ: NBRV) opened for trading at $11.39 after pricing 9,000,000 American Depositary Shares (ADSs), representing 900,000 of its common shares, at a public offering price of $10.25 per ADS. The pricing was a smidge below the expected... More
Nabriva Therapeutics AG (NBRV) IPO Prices at $10.25/ADS, Slightly Below Expectations
September 18, 2015 8:46 AM EDTNabriva Therapeutics AG (NASDAQ: NBRV) announced he pricing of its initial public offering of 9,000,000 American Depositary Shares (ADSs), representing 900,000 of its common shares, at a public offering price of $10.25 per ADS. The pricing was a smidge below the expected $10.50/ADS. Shares are... More



